Dr Silvia Oggero
Post Doctoral Research Assistant
Biochemical Pharmacology, The William Harvey Research Institute
Queen Mary University of London
Queen Mary University of London
Research
Interests
interest and expertise in all in vitro models which wil mimick inflammation and are crucial in the resolution process in various chronic diseases.Publications
2020
Immuno-moodulin: A new anxiogenic factor produced by Annexin-A1 transgenic autoimmune-prone T cellsPiras G, Rattazzi L, Paschalidis N, Oggero S, Berti G, Ono M, Bellia F, D'Addario C et al.
Brain, Behavior, and Immunity, Elsevier Bv vol. 87, 689-702.
01-07-2020
Imbalance of proresolving lipid mediators in persistent allodynia dissociated from signs of clinical arthritisAllen BL, Montague-Cardoso K, Simeoli R, Colas RA, Oggero S, Vilar B, McNaughton PA, Dalli J et al.
Pain, Ovid Technologies (Wolters Kluwer Health) vol. 161 (9), 2155-2166.
04-05-2020
2019
The Contrasting Role of Extracellular Vesicles in Vascular Inflammation and Tissue RepairOggero S, Austin-Williams S, Norling LV
Frontiers in Pharmacology, Frontiers Media Sa vol. 10
17-12-2019
2018
Microvesicle Subsets in Sepsis Due to Community Acquired Pneumonia Compared to Faecal PeritonitisLashin HMS, Nadkarni S, Oggero S, Jones HR, Knight JC, Hinds CJ, Perretti M
Shock, Ovid Technologies (Wolters Kluwer Health) vol. 49 (4), 393-401.
01-04-2018
2017
ROLE OF THE β-D-ENDOGLUCURONIDASE HEPARANASE IN SEPTIC CARDIOMYOPATHYMartin L, Chen J, Zechendorf E, Chiazza F, Oggero S, Collino M, Marx G, Schuerholz T et al.
01-01-2017
2016
The synthetic antimicrobial peptide 19-2.5 attenuates septic cardiomyopathy and prevents down-regulation of SERCA2 in polymicrobial sepsisMartin L, Horst K, Chiazza F, Oggero S, Collino M, Brandenburg K, Hildebrand F, Marx G et al.
Scientific Reports vol. 6
17-11-2016